期刊文献+

上海地区HIV/HCV重叠感染者HCV准种的分子流行病学研究

Molecular epidemic of HCV quasispecies variability in HIV/HCV coinfection patients from Shanghai
下载PDF
导出
摘要 目的观察HIV/HCV重叠感染和高效抗反转录病毒治疗(HAART)对HCV准种的影响。方法通过PCR、测序及单链构象多态性分析建立HCV高变1区(HVR1)准种变异率检测方法,运用该方法对我国上海地区48例HIV/HCV重叠感染者HCV准种变异的分子流行病学进行研究。结果与单独HCV感染组和HIV/HCV重叠感染且已行HAART组相比较,HIV/HCV重叠感染但未行HAART组的HCV准种变异率较低,差异有统计学意义(P均<0.05)。单独HCV感染组与HIV/HCV重叠感染且已行HAART组之间作比较,HCV准种的复杂性和多样性差异均无统计学意义。结论 HIV感染可降低HCV准种变异率。随着HAART长期应用,HIV/HCV重叠感染者的HCV准种率增加。 Objective To observe the molecular epidemic effects of human immunodeficiency virus(HIV)/HCV coinfection and HAART on HCV quasispecies variability.Methods We detected quasispecies of HCV hypervariable region 1(HVR1)by PCR,nucleotide sequencing and single-stranded conformation polymorphism method.We used the method in 48 subjects from Shanghai and observed the molecular epidemiology of HCV quasispecies variability in HIV-HCV coinfection of the region.Results This study shows that HIV-positive,HAART-naive subjects had significantly lower HCV quasispecies complexity and diversity than HIV-negative and HIV-positive HAART-treated subjects(P0.05).Conclusion HIV coinfection is associated with decreased HCV quasispecies variability,which appears to be reversed by effective HAART.
出处 《肝脏》 2011年第4期291-294,共4页 Chinese Hepatology
基金 上海市科委自然科学基金(06ZR1401) 上海卫生局课题(054034)
关键词 人类免疫缺陷病毒 丙型肝炎 准种 Human immunodeficiency virus Hepatitis C virus Quasispeceis
  • 相关文献

参考文献15

  • 1Soriano V, Rodriguez-Rosado R, Gareia-Samaniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS, 1999, 13 : 539- 546.
  • 2Staples CT Jr, Rimland D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis, 1999, 29:150-154.
  • 3Sherman KE, Rouster SD, Chung RT, et al.. Hepatitis C virus prevalence among patients infected with human immunodefieiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis, 2002, 34:831-837.
  • 4Benhamou Y, Di Martino V, Bochet M, et al. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.Hepatology, 2001, 34:283-287.
  • 5Qurishi N, Kreuzberg C, Luchters G, et al. Effect of antiretroviral therapy on liver-reLated mortality in patients with HIV and hepatitis C virus coinfection. Lancet, 2003, 362 : 1708-1713.
  • 6Wilson JJ, Polyak SJ, Day TD, et al. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex el shift analysis: correlation with nucleotide sequencing. J Gen Virol, 1995, 76: 1763-1771.
  • 7Tagariello G, Gerotto M, Pontisso P, et al. Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophilia. Haemophilia, 2004, 10: 81-86.
  • 8Qin H, Shire NJ, Keenan ED, et al. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood, 2005, 105:533-541.
  • 9Odeberg J, Yun Z, Sonnerborg A, et al. Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis, 1997, 175:938-1043.
  • 10Sherman KE, Andreatta C, O'Brien J, et al. Hepatitis C in human immunodeficiency virus - coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology, 1996, 23: 688-694.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部